EWV-17976-17331
3 vaccinations
5 coded responses
40 check-ins
5 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 015 / MA
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 1 — Pfizer-BioNTech
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
-
2021-03-19
Health check-in — day 0, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-06-18
Survey response — 3 months, dose 2MedDRA: Breast cancer, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Recently diagnosed with breast cancer · Healthcare visit (other): Biopsies, ultrasounds, chip implant. Surgery scheduled for 7-1-2021MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-24
Call successfulCompleted over the phone
-
2021-09-17
Survey response — 6 months, dose 2MedDRA: Alopecia, Breast cancer, Chemotherapy, Nausea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Breast cancer Nausea Hair loss · Healthcare visit (other): Undergoing chemotherapyMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-20
Call successfulCompleted over the phone
-
2021-10-06
Dose 3 — Pfizer-BioNTech
- 2021-10-06
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-20
- 2021-10-27
-
2021-11-03
Survey response — day 28, dose 3MedDRA: Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Chemotherapy induced neuropathy · Healthcare visit (other): In clinic at regular chemotherapy treatmentMedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-04
- 2021-11-11
- 2021-11-17
-
2022-01-05
Survey response — 3 months, dose 3MedDRA: Medical counselling, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Chemotherapy induced neuropathy. · Healthcare visit (other): Telephone callMedDRA releases: 2024-11 · check-in free text available
-
2022-01-05
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-06
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-07
-
2022-10-06
Survey response — 12 months, dose 3MedDRA: Neurological symptom, Neuropathy peripheral, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: On going care from breast cancer diagnosis may, 2021. Neurological issues including neuropathy. Undergoing further evaluation at this time for spinal issues.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
Call center
5 call center cases
4 successful · 1 unsuccessful
VAERS report filed, before or during a call: 2
Free text
Release 9 — 3 months, dose 2
Symptoms: Recently diagnosed with breast cancer
Healthcare visit (other): Biopsies, ultrasounds, chip implant. Surgery scheduled for 7-1-2021
Release 9 — 6 months, dose 2
Symptoms: Breast cancer Nausea Hair loss
Healthcare visit (other): Undergoing chemotherapy
Release 10 — day 28, dose 3
Symptoms: Chemotherapy induced neuropathy
Healthcare visit (other): In clinic at regular chemotherapy treatment
Release 10 — 3 months, dose 3
Release 12 — 12 months, dose 3
Symptoms: On going care from breast cancer diagnosis may, 2021. Neurological issues including neuropathy. Undergoing further evaluation at this time for spinal issues.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Chemotherapy | · | · | ✓ |
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Alopecia | · | · | ✓ |
| SD | Breast cancer | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Neurological symptom | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release